Sana Biotechnology SANA EPS (Basic)
EPS (Basic) at other companies
Other financials
Where this comes from
Reported directly by Sana Biotechnology in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.
The official record: Sana Biotechnology’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sana Biotechnology's eps (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sana Biotechnology's EPS (basic)?
- Sana Biotechnology (SANA) reported EPS (basic) of -$0.17 in Q1 2026.
- How has Sana Biotechnology's EPS (basic) changed year-over-year?
- Sana Biotechnology's EPS (basic) increased by 19.0% year-over-year, from -$0.21 to -$0.17.
- What is the long-term trend for Sana Biotechnology's EPS (basic)?
- Over 4 years (2021 to 2025), Sana Biotechnology's EPS (basic) has grown at a -17.9% compound annual growth rate (CAGR), from -$2.14 to -$0.97.
- What does EPS (basic) mean?
- Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.